Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis

BACKGROUND: Heparin-induced thrombocytopenia (HIT) causes thromboembolic complications which threaten life and limb. Heparin is administered to virtually every critically ill patient as a protective measure against thromboembolism. Argatroban is a promising alternative anticoagulant agent. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Se-Chan, Tran, Nicole, Schewe, Jens-Christian, Boehm, Olaf, Wittmann, Maria, Graeff, Ingo, Hoeft, Andreas, Baumgarten, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332969/
https://www.ncbi.nlm.nih.gov/pubmed/25879883
http://dx.doi.org/10.1186/s13019-015-0214-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332969/
https://www.ncbi.nlm.nih.gov/pubmed/25879883
http://dx.doi.org/10.1186/s13019-015-0214-0

Ejemplares similares